Christopher W. Wilson

Novartis (United States)

Christopher W. Wilson has made significant contributions to various fields of study, including vascular biology, cell signaling, and developmental biology. Research on Rasip1 has revealed its role in controlling dynamic cell behaviors during angiogenesis and anastomosis, as well as regulating vertebrate vascular endothelial junction stability through epac1-rap1 signaling. Additionally, studies have identified novel modulators of intraocular pressure, gonadotropin-releasing hormone gene expression, and ciliary protein function, highlighting the importance of Rasip1 in maintaining cellular homeostasis. Wilson's work also sheds light on hedgehog signaling, exploring the evolution and regulation of this critical pathway in vertebrates.